Sawai Group (OTCMKTS:SWGHF – Get Free Report) is anticipated to announce its resultson Friday, May 15th. Analysts expect the company to announce earnings of $0.1757 per share and revenue of $314.1510 million for the quarter.
Sawai Group Price Performance
OTCMKTS:SWGHF opened at $12.03 on Wednesday. The business’s 50 day moving average is $12.03 and its two-hundred day moving average is $11.97. Sawai Group has a 52 week low of $11.52 and a 52 week high of $12.03.
About Sawai Group
Sawai Group (OTCMKTS:SWGHF) is a Japan‐based pharmaceutical company primarily focused on the development, manufacturing and marketing of generic medications. Established in 1975 and headquartered in Osaka, Sawai Group has grown to become one of the leading producers of oral solid dosage forms in the Japanese market. The company’s product portfolio includes tablets, capsules and other formulations for chronic and acute indications, with an emphasis on cost‐effective alternatives to branded therapies.
At the core of Sawai Group’s operations is a vertically integrated manufacturing network that encompasses research and development, quality control and commercial production.
Featured Articles
- Five stocks we like better than Sawai Group
- Navy Catalyst Ignites Odysight’s Growth Engine
- AST SpaceMobile Plummets on Galactic Q1 Miss: Can Vertical Integration Save the SpaceX Rival?
- Axon Surged After Earnings and Is Still Down Over 50% From Highs
- The Event That Could Redefine Apple’s Summer Rally
Receive News & Ratings for Sawai Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sawai Group and related companies with MarketBeat.com's FREE daily email newsletter.
